MEDTRONIC PLC (MDT)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for MDT
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| MDT | Chairman of the Board | 60 | ["Current Chairman of the Board of Zeus Company","Board member of Parexel International since 2023","Interim CEO for Dentsply Sirona during 2022","President & CEO at Hill-Rom from May 2018 until 2021","Executive vice president and president of the Interventional Segment at Becton, Dickinson and Company","Leadership positions at Boston Scientific Corporation and Guidant Corporation","Bachelor's degree in Mechanical Engineering from Kettering University","MBA from Columbia University","More than 30 years of global leadership experience in medical device sectors"] | ["M","Growth","Nominating and Corporate Governance","Audit","Operations"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| XRAY | Director | [] | ["Science and Technology Committee"] | 2024 |
Biography sourced from the proxy statement filing.
Mr. Groetelaars is the current Chairman of the Board of Zeus Company, a privately-owned producer of advanced polymer components used in life-saving medical procedures, a role he has held since 2024. Mr. Groetelaars also serves on the Board of Parexel International, a global clinical research organization, since 2023. Previously, Mr. Groetelaars served as interim CEO for Dentsply Sirona during 2022 and was President & CEO at Hill-Rom from May 2018 until the company s acquisition by Baxter International, Inc. in 2021. At Hill-Rom, he provided global leadership for a healthcare technology company with $3 billion in revenue and 10,000+ employees, and led a transformation of the business vision and strategy, growing the portfolio, and driving record financial performance. Prior to joining Hill-Rom, Mr. Groetelaars served as executive vice president and president of the Interventional Segment at Becton, Dickinson and Company (BD) following its acquisition of C.R. Bard in December 2017. He previously served in a variety of progressive roles at C.R. Bard during his 10-year career there, including as a group president from 2015 to 2017. Mr. Groetelaars has also held various leadership positions at Boston Scientific Corporation and with Guidant Corporation. He holds a bachelor s degree in Mechanical Engineering from Kettering University and an MBA from Columbia University.